Industry Reports
Aegerion to acquire AstraZeneca’s lipodystrophy treatment Myalept for $325m
Aegerion Pharmaceuticals has signed an agreement to acquire an orphan product Myalept (metreleptin for injection) from AstraZeneca. AstraZeneca will receive $325m...
News
Hilleman signs MoU with Bangladesh firms to develop oral cholera vaccine
Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to...
Research Insight
Hilleman signs MoU with Bangladesh firms to develop oral cholera vaccine
Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to...
Research Insight
FDA approves Amgen’s BLA for high cholesterol treatment evolocumab
Amgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The...
Research Insight
Takeda and GE Healthcare partner to develop therapeutic drugs for liver diseases
Japan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic fibrosis. Hepatic fibrosis is...
News
Servier to market Intarcia’s type 2 diabetes treatment outside US and Japan
France-based pharmaceutical research company Servier has partnered with Intarcia Therapeutics to develop and commercialise its ITCA 650, outside the US and Japan. ...
Press Releases
GSK seeks European approval for eltrombopag to treat severe aplastic anaemia
British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read